Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000723384 | SCV000112479 | uncertain significance | not provided | 2015-05-08 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001081258 | SCV000560819 | benign | Duchenne muscular dystrophy | 2024-11-15 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000723384 | SCV000603376 | benign | not provided | 2021-11-11 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000723384 | SCV001908447 | benign | not provided | 2020-02-07 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002453402 | SCV002614315 | benign | Cardiovascular phenotype | 2022-08-11 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Natera, |
RCV001831843 | SCV002085448 | likely benign | Becker muscular dystrophy; Duchenne muscular dystrophy; Cardiomyopathy; Dystrophin deficiency | 2019-06-21 | no assertion criteria provided | clinical testing |